• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Impact of point-of-care testing for respiratory viruses on antibiotic use in adults with exacerbation of airways disease: further analysis form a rand

tetano

Editor, Senior Moderator
J Infect. 2019 Jun 21. pii: S0163-4453(19)30191-4. doi: 10.1016/j.jinf.2019.06.010. [Epub ahead of print]
[h=1]Impact of point-of-care testing for respiratory viruses on antibiotic use in adults with exacerbation of airways disease: further analysis form a randomised controlled trial.[/h] Brendish NJ[SUP]1[/SUP], Mills S[SUP]2[/SUP], Ewings S[SUP]3[/SUP], Clark TW[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] The ResPOC study demonstrated that syndromic molecular point-of-care testing (POCT) for respiratory viruses was associated with early discontinuation of unnecessary antibiotics compared to routine clinical care. Subgroup analysis suggests these changes occur predominantly in patients with exacerbation of airways disease. Use of molecular POCT for respiratory viruses is becoming widespread but there is a lack of evidence to inform the choice between multiplex syndromic panels versus POCT for influenza only.
[h=4]MATERIALS/METHODS:[/h] We evaluated patients from the ResPOC study with exacerbation of asthma or COPD who were treated with antibiotics. The duration of antibiotics and proportion with early discontinuation were compared between patients testing positive and negative for viruses by POCT, and controls. Patients testing positive for viruses by POCT were compared according to virus types.
[h=4]RESULTS:[/h] 118 patient with exacerbation of airways disease received antibiotics in the POCT group and 111 in the control group. In the POCT group 49/118(42%) patients tested positive for viruses. Of those testing positive for viruses 17/49(35%) had early discontinuation of antibiotics versus 9/69(13%) testing negative and 7/111(6%) of controls, p<0.0001. Of those positive for viruses by POCT 10/49(20%) were positive for influenza, 21/49 43%) for rhinovirus and 18/49(37%) for other viruses. The proportion with early discontinuation of antibiotics was not different between the virus types (p=0.34).
[h=4]CONCLUSIONS:[/h] This data suggested that syndromic molecular POCT for respiratory viruses should be favoured over POCT for influenza alone in adults with exacerbation of airways disease.
Copyright ? 2019. Published by Elsevier Ltd.


[h=4]KEYWORDS:[/h] Airways disease; Antibiotic use; Hospital; Point-of-care testing; Respiratory viruses; Syndromic

PMID: 31233809 DOI: 10.1016/j.jinf.2019.06.010
 
Back
Top Bottom